<DOC>
	<DOCNO>NCT01941641</DOCNO>
	<brief_summary>Objective tumour response rate FOLFOXIRI pre-operative therapy .</brief_summary>
	<brief_title>Colon Neoadjuvant FOLFOXIRI Study</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Age &gt; = 18 year either sex . ECOG performance status 01 Measurable disease RECIST 1.1 criterion . Histologically confirm rectal adenocarcinoma ( define either mid low rectal cancer locate within 12 cm anal verge OR peritoneal reflection ) previously untreated . 'High risk ' rectal cancer , rectal cancer consider marginally operable significant risk positive surgical margin : T3 ( lowlying tumour levator ) T4 , Tumour infiltrate perirectal fat , Any Tstage ( T14 ) nodepositive tumour ( invade surround structure peritoneum ) Adequate bone marrow , renal hepatic function define : absolute neutrophil count &gt; = 1.5 x 109/L , hemoglobin &gt; = 9 g/L , platelet &gt; = 100 x 109/L , calculate creatinine clearance &gt; = 55 ml/min , total bilirubin = &lt; 1.5 x upper limit normal , alanine aminotransferase ( ALT ) = &lt; 2.5 upper limit normal . Known distant metastasis , even metastasis resect . History another invasive malignancy within last 5 year , except treat basal cell carcinoma skin , cervical intraepithelial neoplasia , noninvasive DCIS breast . Upper rectal cancer locate peritoneal reflection . Primary tumour associate one follow feature : Frank intestinal obstruction , Endoscope unable pas tumour 's lumen plus worsen local obstructive symptom . Note : Patients feature assess surgical team regard stomal bypass prior study enrolment . Such patient still consider study enrolment undergo stomal bypass . Known hypersensitivity reaction study drug ( i.e . fluoropyrimidine , irinotecan , oxaliplatin ) Known peripheral neuropathy grade 2 severity . Patients receive experimental anticancer therapy within last 28 day . Previous pelvic radiotherapy . Previous oxaliplatin irinotecan treatment colon rectal cancer Patient hip prosthesis Major surgery within last 28 day . Exception : Any patient underwent stomal bypass obstruct primary tumour within last 14 day still eligible , long patient sufficiently recover surgery investigator 's discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>